In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells

Immunology. 1994 Jan;81(1):53-7.

Abstract

Doxorubicin-stimulated whole rat glomeruli and dissociated mesangial and resident glomerular macrophage cells produced the release of interleukin (IL)-1 beta cytokine. This activity increased after the addition of lipopolysaccharide (LPS) or LPS plus indomethacin to the cultures. In the presence of WEB2086 [platelet-activating factor (PAF)-acether antagonist], this activity showed a drastic reduction, without modification after sodium furegrelate (thromboxane synthetase inhibitor) was added to the cultures. Our results also demonstrate that this IL-1 beta activity is mainly produced by glomerular-resident macrophage cells. These findings support the important role by both IL-1 beta and PAF-acether mediator factors, at the cellular level, in the rat model of doxorubicin-induced nephrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azepines / pharmacology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology*
  • Drug Interactions
  • Glomerular Mesangium / drug effects
  • Glomerular Mesangium / immunology
  • Interleukin-1 / chemistry
  • Interleukin-1 / metabolism*
  • Kidney Glomerulus / drug effects*
  • Kidney Glomerulus / immunology
  • Kinetics
  • Lipopolysaccharides / pharmacology
  • Male
  • Molecular Weight
  • Platelet Activating Factor / antagonists & inhibitors
  • Rats
  • Rats, Sprague-Dawley
  • Triazoles / pharmacology

Substances

  • Azepines
  • Interleukin-1
  • Lipopolysaccharides
  • Platelet Activating Factor
  • Triazoles
  • WEB 2086
  • Doxorubicin